Application 219701
- Type
- ANDA
- Sponsor
- ANTHEA PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SODIUM BICARBONATE | SODIUM BICARBONATE | SOLUTION;INTRAVENOUS | 50MEQ/50ML (1MEQ/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219701-001 | SODIUM BICARBONATE | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2025-06-26 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219701-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219701-001 | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2025-06-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219701-001 | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2025-06-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A219701-001 | SODIUM BICARBONATE | 1MEQ/ML | INJECTABLE / INJECTION | AP | 2025-06-26 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219701-001 | SODIUM BICARBONATE | 50MEQ/50ML (1MEQ/ML) | SOLUTION / INTRAVENOUS | AP | 2025-06-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A219701-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219701-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A219701-001 | AP | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219701-001 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SODIUM BICARBONATE | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC. | 5401e4ff-aa7a-3e97-e063-6294a90a24f0 | 2026-06-11 | Warnings, Adverse reactions | 219701 ANDA219701 |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Glenmark Pharmaceuticals Inc., USA | f38d0dfc-9bcc-4224-a202-885c9ad0beae | 2025-11-20 | Warnings, Adverse reactions | 219701 ANDA219701 |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Anthea Pharma Private Limited | 0df8cf62-4b49-4ec4-aae4-c4a3e6d76549 | 2025-06-26 | Warnings, Adverse reactions | 219701 ANDA219701 |